Aptevo Therapeutics Inc. Gains 44.2%
Thu, Apr 03, 2025 at 08:03 PM
Aptevo Therapeutics Inc. (APVO:NASDAQ) soared at $1.99, representing a gain of 44.2%. On Thu, Apr 03, 2025, APVO:NASDAQ hit a New 2-Week Intraday High of $2.64. The stock appeared on our News Catalysts scanner on Thu, Apr 03, 2025 at 09:09 AM in the 'PRIVATE PLACEMENT' category. From Thu, Mar 20, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Apr 02, 2025 at $3.61 with a volume of 21M+.
About Aptevo Therapeutics Inc. (APVO:NASDAQ)
Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.
Top 10 Gainers:
- MEDIROM Healthcare Technologies Inc. (MRM:NASDAQ), 92.92%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- OSR Holdings Inc. (OSRH:NASDAQ), 68.03%
- Alaunos Therapeutics Inc Com (TCRT:NASDAQ), 50.71%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 49.85%
- Genprex, Inc. (GNPX:NASDAQ), 46.31%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 44.2%
- NeOnc Technologies Holdings Inc. (NTHI:NASDAQ), 36.86%
- Local Bounti Corporation (LOCL:NYSE), 34.29%
- Direxion Daily Semiconductor Bear 3X Shares (SOXS:NYSE), 29.8%